"Weight-Loss Drugs Show Promise in Treating Sleep Apnea, Studies Find"

A new study suggests that tirzepatide, a weight-loss drug also known as Zepbound, may potentially reduce the severity of obstructive sleep apnea in those with the condition, while also aiding in weight loss. If approved, this could provide another treatment option for sleep apnea sufferers. However, the drug may not be suitable for all patients, and there are reports of shortages for tirzepatide and semaglutide injections. Additionally, there are concerns about unexpected pregnancies linked to the use of weight-loss drugs like Ozempic and Wegovy, highlighting the broader impact of these medications on health.